New cancer institute’s world-leading research and treatment


A new cancer institute in South Australia will deliver world-leading patient care, cutting-edge cancer diagnoses and treatments, and ground-breaking research.

The new South Australian immunoGENomics Cancer Institute (SAiGENCI) has been established with $80 million in funding from the Australian Government, and builds on the collective efforts of the University of Adelaide, the State Government of South Australia and the Central Adelaide Local Health Network (CALHN).

SAiGENCI will join a network of the world’s leading cancer research institutes to meet the global challenge of developing innovative, new treatments for cancer patients, including in Australia.


Tagged in engagement enews